This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Senseonics Holdings (SENS) and Wuxi Biologics (Cayman) (OtherWXIBF)

Tipranks - Wed Jun 10, 7:24PM CDT

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Senseonics Holdings (SENS) and Wuxi Biologics (Cayman) (WXIBF) with bullish sentiments.

Introducing TipRanks MCP for Agents

Senseonics Holdings (SENS)

In a report released yesterday, Josh Jennings from TD Cowen maintained a Buy rating on Senseonics Holdings. The company’s shares closed last Tuesday at $7.43.

According to TipRanks.com, Jennings is a 3-star analyst with an average return of 1.3% and a 45.2% success rate. Jennings covers the Healthcare sector, focusing on stocks such as Anteris Technologies Global Corp., Establishment Labs Holdings, and Orchestra BioMed Holdings. ;'>

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Senseonics Holdings with a $16.67 average price target, implying a 131.5% upside from current levels. In a report issued on June 8, Lake Street also maintained a Buy rating on the stock with a $12.00 price target.

See today’s best-performing stocks on TipRanks >>

Wuxi Biologics (Cayman) (WXIBF)

In a report issued on June 8, Laurence Tam from Morgan Stanley maintained a Buy rating on Wuxi Biologics (Cayman), with a price target of HK$50.00. The company’s shares closed last Wednesday at $4.40.

Tam has an average return of 0.2% when recommending Wuxi Biologics (Cayman). ;'>

According to TipRanks.com, Tam is ranked #10068 out of 12293 analysts.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Wuxi Biologics (Cayman) with a $5.78 average price target.

Read More on SENS:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.